Role of thoracic radiotherapy for extensive-stage small cell lung cancer in the era of immunotherapy: a review of current evidence

Extensive-stage small cell lung cancer (ES-SCLC) is an aggressive malignancy with an extremely poor prognosis. For a long time, platinum-based chemotherapy combined with etoposide has been the primary treatment option. Although the initial response rate is high, the vast majority of patients face th...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Zhipeng Li, Xiao Lei, Xingdong Guo, Qiduo He, Yanan Han, Pei Zhang, Lehui Du, Baolin Qu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-04-01
Edice:	Frontiers in Immunology
Témata:	biomarkers chemotherapy extensive-stage small cell lung cancer immunotherapy thoracic radiotherapy
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1769165/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!